Rbc Sciences Biologiques Fund Current Valuation

0P00007138  CAD 53.20  0.03  0.06%   
Valuation analysis of RBC sciences biologiques helps investors to measure RBC Sciences' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Fairly Valued
Today
53.20
Please note that RBC Sciences' price fluctuation is very steady at this time. At this time, the entity appears to be fairly valued. RBC sciences biologiques owns a latest Real Value of C$52.59 per share. The recent price of the fund is C$53.2. We determine the value of RBC sciences biologiques from evaluating fund fundamentals and technical indicators as well as its Probability Of Bankruptcy. In general, we support taking in undervalued funds and trading overvalued funds since, in the future, fund prices and their ongoing real values will converge.
Since RBC Sciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of RBC Fund. However, RBC Sciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  53.2 Real  52.59 Hype  53.2 Naive  52.71
The real value of RBC Fund, also known as its intrinsic value, is the underlying worth of RBC sciences biologiques Fund, which is reflected in its stock price. It is based on RBC Sciences' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of RBC Sciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
52.59
Real Value
53.57
Upside
Estimating the potential upside or downside of RBC sciences biologiques helps investors to forecast how RBC fund's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of RBC Sciences more accurately as focusing exclusively on RBC Sciences' fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
51.4653.0754.69
Details
Hype
Prediction
LowEstimatedHigh
52.2253.2054.18
Details
Naive
Forecast
LowNext ValueHigh
51.7352.7153.70
Details

RBC sciences biologiques Fund Current Valuation Analysis

RBC Sciences' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, RBC sciences biologiques has a Current Valuation of 0.0. This indicator is about the same for the RBC Global Asset Management Inc. average (which is currently at 0.0) family and about the same as US Equity (which currently averages 0.0) category. This indicator is about the same for all Canada funds average (which is currently at 0.0).

Did you try this?

Run Equity Analysis Now

   

Equity Analysis

Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
All  Next Launch Module

Fund Asset Allocation for RBC Sciences

The fund consists of 97.28% investments in stocks, with the rest of investments allocated between different money market instruments.
Asset allocation divides RBC Sciences' investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.

RBC Fundamentals

About RBC Sciences Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze RBC sciences biologiques's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RBC Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RBC sciences biologiques based on its fundamental data. In general, a quantitative approach, as applied to this fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with RBC Sciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if RBC Sciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RBC Sciences will appreciate offsetting losses from the drop in the long position's value.

Moving together with RBC Fund

  0.960P0000OXA6 PHN Multi StylePairCorr
  0.980P000077P2 RBC DividendPairCorr
  0.90P0000716B Mawer Equity APairCorr
  0.950P000071W8 TD Index FundPairCorr
  0.930P0000706A RBC Select BalancedPairCorr
The ability to find closely correlated positions to RBC Sciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace RBC Sciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back RBC Sciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling RBC sciences biologiques to buy it.
The correlation of RBC Sciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as RBC Sciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if RBC sciences biologiques moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for RBC Sciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in RBC Fund

RBC Sciences financial ratios help investors to determine whether RBC Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in RBC with respect to the benefits of owning RBC Sciences security.
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios